Therapeutic B-cell depletion with obinutuzumab modulates key immunopathological pathways in lupus nephritis: an exploratory whole blood transcriptomic analysis of the phase II NOBILITY trial
In one of the most detailed molecular portraits yet of how a next-generation antibody rewrites the immune system in lupus, ...
